{"id":"https://genegraph.clinicalgenome.org/r/d1230a85-2a8b-4321-b36d-213daae9a28av1.6","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *ABCD1* and adrenoleukodystrophy (ABCD1 deficiency), including X-linked cerebral adrenoleukodystrophy and adrenomyeloneuropathy (AMN), and isolated adrenal insufficiency, inherited in the X-linked pattern, has been evaluated using the ClinGen Clinical Validity Framework as of November, 2020. This association was made using case-level and experimental data. The *ABCD1* gene encodes an ATP-binding cassette half-transporter (ALDP) located in peroxisomes. Using positional cloning, Moser et al. (1993) discovered that this gene was partially deleted in 6 of 85 unrelated patients with adrenoleukodystrophy (ALD), who exhibit neurological symptoms as well as the pathognomonic feature of very long chain fatty acid (VLCFA) accumulation. Since then, several hundreds of inherited and de novo variants (including missense, nonsense, splice site, delins and structural arrangements) have been associated with ABCD1 deficiency, many of which have decreased or absent protein expression and localization at the peroxisomes (PMIDs: 7825602, 8651290, 11748843, 15811009, 21700483). \n\nSummary of Case Level Data (12 points): The association is seen in at least 33 probands in 4 publications (PMID: 15811009, 8651290, 7825602, 21700483). More case-level evidence is available in the literature, but the maximum score for genetic evidence (12 pts) has been reached.\n\nThe mechanism for disease is expected to be hemizygous loss of function. Female carriers are sometimes symptomatic with elevated VLCFA levels.\n\nSummary of Experimental Data (6 points): ALDP is shown to be reduced or absent in expression in patients with ABCD1 deficiency. Mice deficient in ALDP do not phenocopy the neurologic disturbances typical of childhood-onset ALD, but do exhibit VLCFA accumulation (PMID: 9256488, 7878038). However, mouse models do recapitulate the adult-onset AMN phenotype (11875044, 15489218). ALDP interacts with PEX19, another peroxisome membrane protein that is implicated in peroxisome biogenesis disorders. Rescue in patient cells has been shown with expression of recombinant ALDP restoring peroxisome beta-oxidation. Lentiviral-mediated gene therapy in ALD patients has shown to mitigate major functional disabilities in childhood patients with ALD (PMID: 28976817). Blocking ABCD1 in healthy fibroblasts leads to VLCFA accumulation similar to that seen in patients with XALD (PMID: 23671276).\n\nIn summary, *ABCD1* is definitively associated with adrenoleukodystrophy (ABCD1 deficiency). This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Peroxisomal Disorders GCEP on December 18, 2020 (SOP Version 7).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d1230a85-2a8b-4321-b36d-213daae9a28a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/815e0f84-b530-4fd2-81a9-02e02bf352ee","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/815e0f84-b530-4fd2-81a9-02e02bf352ee_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10049","date":"2022-04-21T21:16:41.779Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/815e0f84-b530-4fd2-81a9-02e02bf352ee_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10049","date":"2020-12-18T05:00:00.000Z","role":"Approver"},{"agent":"https://genegraph.clinicalgenome.org/agent/10006","role":"SecondaryContributor"}],"curationReasonDescription":"Correcting to reflect previously approved curation.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/815e0f84-b530-4fd2-81a9-02e02bf352ee_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2141330-16c8-4302-a8ab-05ebc58612bf","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2141330-16c8-4302-a8ab-05ebc58612bf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/09d3550d-330e-4afe-b39a-04d4677f93d6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1073C>G (p.Ser358Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415101332"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1c7289a0-451a-4459-a68c-0bf8dc4f8945","type":"EvidenceLine","dc:description":"Missense variant without functional evidence. Noted de novo.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c7289a0-451a-4459-a68c-0bf8dc4f8945_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21700483","allele":{"id":"https://genegraph.clinicalgenome.org/r/a081a26b-60cd-42c3-8ecc-01fb0c171b41","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1679C>T (p.Pro560Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA278408"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/455525d7-ba7f-45e0-9056-ab3bc356b78c","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/455525d7-ba7f-45e0-9056-ab3bc356b78c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/e850e2af-82a4-4ebd-b662-2bff56379e87","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.323C>A (p.Ser108Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415098622"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b65de34f-f9ff-418a-ae92-66a38bb6f2ea","type":"EvidenceLine","dc:description":"Missense variant without functional evidence. Noted de novo.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b65de34f-f9ff-418a-ae92-66a38bb6f2ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21700483","allele":{"id":"https://genegraph.clinicalgenome.org/r/6d59a123-82be-476d-badb-b975dd941d47","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1201C>T (p.Arg401Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415105485"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6d94b4fa-bd87-465e-9377-3b2e6ea1c414","type":"EvidenceLine","dc:description":"Multiple affected, unrelated probands carry this variant. However, no functional evidence is available.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d94b4fa-bd87-465e-9377-3b2e6ea1c414_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8651290","allele":{"id":"https://genegraph.clinicalgenome.org/r/a081a26b-60cd-42c3-8ecc-01fb0c171b41"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2df2f495-77e4-404c-9a2e-18e862992cd0","type":"EvidenceLine","dc:description":"Missense variant without functional evidence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2df2f495-77e4-404c-9a2e-18e862992cd0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/14e53fb9-86e2-4082-9e17-d6f436684695","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.871G>A (p.Glu291Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/11292"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7e9ea7a8-406e-4d07-8b54-5fc3a2ad0550","type":"EvidenceLine","dc:description":"Proband with nonsense variant in exon 1/10. NMD is predicted.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e9ea7a8-406e-4d07-8b54-5fc3a2ad0550_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7825602","allele":{"id":"https://genegraph.clinicalgenome.org/r/1841cf7d-8a79-4d79-8856-3f7fb312ba68","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.543C>A (p.Tyr181Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415099077"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c7efdbf7-a304-4d7e-b14c-c68aed803173","type":"EvidenceLine","dc:description":"Missense variant\nwithout functional\nevidence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7efdbf7-a304-4d7e-b14c-c68aed803173_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/f0115705-82df-4efc-8574-ce6741116373","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.836T>C (p.Leu279Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415100118"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/39b09080-92a6-4056-a6fd-2f38df178f97","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39b09080-92a6-4056-a6fd-2f38df178f97_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/eb248f65-af30-409c-9e50-de07498a4f2e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1699C>T (p.Gln567Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10550293"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e5072e14-ec81-4470-b8c2-957d06ea2c23","type":"EvidenceLine","dc:description":"Variant identified in multiple unrelated probands, reported in 3 separate articles. However, no functional evidence available.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5072e14-ec81-4470-b8c2-957d06ea2c23_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d433c77-9b9d-402c-9bc1-780fa11f686f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1628C>T (p.Pro543Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415112044"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e10007a0-3054-4d68-8136-0c867b22489f","type":"EvidenceLine","dc:description":"Proband with 2-bp deletion causing frameshift and PTC in exon 7/10 (Gln472ArgfsTer83). NMD is predicted. Note, this variant was observed in 4 kindreds in this study: in 3 of them, variant was detected in the male probands and in one, the variant was identified in carriers (symptomatic mother with reduced VLCFAs and unaffected sisters). This record is scored only for one proband.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e10007a0-3054-4d68-8136-0c867b22489f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7825602","allele":{"id":"https://genegraph.clinicalgenome.org/r/3bb84f5d-dd16-49eb-8755-de9f1c5414dc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1415_1416del (p.Gln472ArgfsTer83)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA278110"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/fde365d6-9084-4a6e-be34-14122a123164","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fde365d6-9084-4a6e-be34-14122a123164_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/39412066-2753-4c14-889a-c6be6a5418d3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1571G>A (p.Trp524Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415111490"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9dff2326-b904-474e-a8a3-af51b1e13a93","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9dff2326-b904-474e-a8a3-af51b1e13a93_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/acecf6cd-1392-4c36-962b-8ef64a6584d0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1186G>A (p.Ala396Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415105353"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/50ce7dee-8624-45e6-a6f5-a01cb11a0847","type":"EvidenceLine","dc:description":"Proband with 1-bp deletion causing frameshift and PTC in exon 1/10 (Val20CysfsTer48). NMD is predicted.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50ce7dee-8624-45e6-a6f5-a01cb11a0847_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7825602","allele":{"id":"https://genegraph.clinicalgenome.org/r/31918242-711d-4177-880b-fde78488f85a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.57del (p.Val20CysfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139532866"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/80f6bc02-fcbd-459b-a205-ec9b20305743","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80f6bc02-fcbd-459b-a205-ec9b20305743_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/2ae074f1-6283-45d0-8b4d-9adfc516edd2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.253dup (p.Arg85ProfsTer110)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA278445"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b365c2a7-0fd5-408e-b7d7-2f80d5768896","type":"EvidenceLine","dc:description":"Missense variant\nwithout functional\nevidence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b365c2a7-0fd5-408e-b7d7-2f80d5768896_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/f1e33a61-f8cb-46e7-bf14-d54ea84a78af","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1682A>T (p.Asp561Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415112699"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f5c43981-3407-47b6-b988-9bedbc9aa274","type":"EvidenceLine","dc:description":"Missense variant without functional evidence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5c43981-3407-47b6-b988-9bedbc9aa274_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/ae15cfc8-22e9-4b98-a7a4-9623a7cc09f7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1850G>A (p.Arg617His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA278116"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6fdd3821-f6d1-4cf2-a1bc-7df22de9cecb","type":"EvidenceLine","dc:description":"Missense variant without functional evidence, noted de novo","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6fdd3821-f6d1-4cf2-a1bc-7df22de9cecb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21700483","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9301a44-0ef0-4735-b7b0-1a3a3597b450","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.796G>A (p.Gly266Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA278105"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/09e9ffeb-24ed-418d-bd82-f51cdde6b87c","type":"EvidenceLine","dc:description":"Missense variant without functional evidence. Noted de novo.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/09e9ffeb-24ed-418d-bd82-f51cdde6b87c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21700483","allele":{"id":"https://genegraph.clinicalgenome.org/r/b5321f82-722e-4105-a2a0-162462639b7e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1876G>A (p.Ala626Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415116649"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0003a3a8-50fb-4885-abf2-a119fcd44d62","type":"EvidenceLine","dc:description":"Proband with nonsense variant in exon 1/10. NMD is predicted.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0003a3a8-50fb-4885-abf2-a119fcd44d62_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7825602","allele":{"id":"https://genegraph.clinicalgenome.org/r/421c7a57-924c-4a6e-b932-795a24d1bbe8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.397C>T (p.Gln133Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415098769"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/40b3a77a-1af8-4b0c-ab67-b6aff89ea040","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40b3a77a-1af8-4b0c-ab67-b6aff89ea040_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/02ba6937-2254-4902-96c1-94b5b27145a3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.931C>T (p.Gln311Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415100619"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/557c209d-8b2c-47b0-af44-75404061b13a","type":"EvidenceLine","dc:description":"Proband with nonsense variant in exon 1/10. NMD is predicted.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/557c209d-8b2c-47b0-af44-75404061b13a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7825602","allele":{"id":"https://genegraph.clinicalgenome.org/r/368744e3-a912-4216-9b7f-1eff3afa41d7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.469C>T (p.Gln157Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415098924"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/da41cc4b-23e5-40b8-a089-cc6ebb07606c","type":"EvidenceLine","dc:description":"Proband with 8-bp deletion causing frameshift and PTC in exon 1/10 (Ser262PhefsTer36). NMD is predicted.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da41cc4b-23e5-40b8-a089-cc6ebb07606c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7825602","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e93eded-445e-4972-b75b-e7bf1b9e4799","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.785_792del (p.Ser262PhefsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139532868"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/79f075ca-d304-4348-a15c-dad7437f776b","type":"EvidenceLine","dc:description":"Missense variant without functional evidence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79f075ca-d304-4348-a15c-dad7437f776b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/f6e126b0-8a78-4ea5-9614-aadbd222aaef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1825G>A (p.Glu609Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/166626"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8c7e9065-fd83-49c5-9b7e-e6e321dc464d","type":"EvidenceLine","dc:description":"Missense variant without functional evidence. Noted de novo.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c7e9065-fd83-49c5-9b7e-e6e321dc464d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21700483","allele":{"id":"https://genegraph.clinicalgenome.org/r/e6582c63-fcd4-4d3c-aeda-51f7ff06979c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1390C>T (p.Arg464Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA278108"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/11192e2b-6d47-4277-adec-79d01961a967","type":"EvidenceLine","dc:description":"Proband with nonsense variant in exon 1/10. NMD is predicted.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11192e2b-6d47-4277-adec-79d01961a967_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7825602","allele":{"id":"https://genegraph.clinicalgenome.org/r/2bfb3615-0cef-4bfd-8cc9-45201916b815","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.411G>A (p.Trp137Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA415098799"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3b82617f-2978-4a9f-b7a8-526c37e8cbd1","type":"EvidenceLine","dc:description":"Missense variant without functional evidence. Noted de novo.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b82617f-2978-4a9f-b7a8-526c37e8cbd1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21700483","allele":{"id":"https://genegraph.clinicalgenome.org/r/f92c3e10-8e01-4587-9820-26627b966613","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1553G>A (p.Arg518Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA278403"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6841021e-be14-4af2-a4f7-1163467d8949","type":"EvidenceLine","dc:description":"Multiple affected kindreds carry this missense variant; without functional evidence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6841021e-be14-4af2-a4f7-1163467d8949_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/c7f2aa7d-00f0-4bdb-b957-c20898016587","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.1661G>A (p.Arg554His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/166625"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/df29a567-85b5-4c52-bbff-24d9a1c6f135","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df29a567-85b5-4c52-bbff-24d9a1c6f135_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/0fe9ecb2-5080-4a50-a012-3c1eead92af6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.529C>T (p.Gln177Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/369726"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/fb43e17c-c864-4074-998e-c1701c963d79","type":"EvidenceLine","dc:description":"Proband with 1-bp deletion causing frameshift and PTC in exon 1/10 (Leu93CysfsTer10). NMD is predicted.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb43e17c-c864-4074-998e-c1701c963d79_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7825602","allele":{"id":"https://genegraph.clinicalgenome.org/r/63fd8a32-8b1d-4686-af86-2120e8009ac7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.277del (p.Leu93CysfsTer10)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139532867"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bd6d809d-01ab-41d0-9c19-e86f2c367fb4","type":"EvidenceLine","dc:description":"Identified in multiple kindreds. Missense variant without functional evidence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd6d809d-01ab-41d0-9c19-e86f2c367fb4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/f92c3e10-8e01-4587-9820-26627b966613"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d511c352-4719-4ed4-be37-f72095253352","type":"EvidenceLine","dc:description":"Missense variant without functional evidence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d511c352-4719-4ed4-be37-f72095253352_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","allele":{"id":"https://genegraph.clinicalgenome.org/r/da390337-f973-415a-86c4-433b79cdb0ba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000033.4(ABCD1):c.521A>G (p.Tyr174Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/458646"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/815e0f84-b530-4fd2-81a9-02e02bf352ee_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/815e0f84-b530-4fd2-81a9-02e02bf352ee_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/078a9062-d749-4b10-9f37-0d2459a63d1a","type":"EvidenceLine","dc:description":"Multiple pathogenic variants associated with disease represented","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c968e11-bc70-4c46-919b-4795eb9792c0","type":"Finding","dc:description":"\"ALDP expression was studied in 46 families, 34 of which were negative for ALDP (74%).\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15811009","rdfs:label":"Coll 2005, Immunostain of fibroblasts from XALD pts","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5c7ba1bf-5021-4191-a9f7-9aa9fd02f63d","type":"EvidenceLine","dc:description":"Multiple pathogenic variants associated with disease represented. This evidence is scored already and therefore noted here for information only.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9805c31d-6ba0-48b2-9c4c-eebe1b69fb18","type":"Finding","dc:description":"\"Twenty-four (69%) of the 35 ALD cell lines lacked the punctate immunoreactive staining pattern characteristic of ALDP (table 2 and fig. 4a), indicating that full-length ALDP is not stably expressed in these cell lines.\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7668254","rdfs:label":"Watkins 1995, Immunostaining of ALD patient fibroblasts","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f9fd8fb3-cdb5-4a9b-8c91-a214c941b22a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e78bcee5-1c11-4ea4-a97b-d4d1975126ce","type":"Finding","dc:description":"Yeast two-hybrid interaction assay was used to demonstrate that ALDP interacted with PEX19p. The interaction activated the LEU2 gene allowing growth on media lacking leucine. This was confirmed when suppression of PEX19p expression by glucose hampered yeast growth. Using a pull-down assay, authors showed that the ALDP-interaction domain on PEX19p lay within its N-terminal region.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10777694","rdfs:label":"Gloeckner_PEX19 interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/815e0f84-b530-4fd2-81a9-02e02bf352ee_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89f7902c-d15b-49b1-942e-18d1ed6fee55","type":"EvidenceLine","dc:description":"The evidence is scored default points as the function of ABCD1 protein in VLCFA oxidation is described and blocking its function is shown to lead to accumulation of VLCFAs, which is one of the primary phenotypes noted in patients with XALD.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/224636b6-1af5-444f-83d1-89ae78e78068","type":"FunctionalAlteration","dc:description":"Authors compared relative β-oxidation activity for free C26:0 and the respective acyl-CoA ester as substrates. β-oxidation of hexacosanoic acid (C26:0) is significantly reduced in X-ALD and absent in ZWS patients. By preincubating with a α-ABCD1 antibody, the C26:0-CoA β-oxidation activity of healthy control samples was decreased to a level similar to that in X-ALD patients. Similar results were noted for unesterified C26:0 as substrate. In X-ALD patients and ZWS patients, the level of C26:0 was strongly elevated, lignoceric acid (C24:0) showed a moderate increase, and C22:0 remained unaltered. The observed C22:0-CoA β-oxidation defect in X-ALD was found to be a direct consequence of ABCD1 dysfunction as blocking of ABCD1 function with a specific antibody decreased β-oxidation activity of healthy controls to a level similar to that observed in X-ALD patients.\n\nPMID: 21145416 provides evidence of the function of ABCD1 in oxidation of VLCFA's in yeast cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23671276","rdfs:label":"Wiesinger_ABCD1 VLCFA oxidation"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/815e0f84-b530-4fd2-81a9-02e02bf352ee_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/394a1821-afd8-4b9f-9483-7ff0868d3e2b","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f18fb0a-a0bd-414a-ac81-85a760de984b","type":"Finding","dc:description":"\"ALDP was absent in one mutated cell line and present but defective in the second. After transduction with the M48-ALD, recombinant ALDP, expressed abundantly, was normally\nincorporated into peroxisomes in the fibroblasts from both patients. The cellular distribution of recombinant ALDP was punctate, as in normal fibroblasts, and colocalized with the\nperoxisomal catalase. Although ALDP was overexpressed, no ALDP aggregates were observed in the cytosol. These results support the observation that, most if not all, recombinant ALDP was correctly targeted to peroxisomes.\n\nThe oxidation of lignoceric acid, a substrate for peroxisomal, B-oxidation, is reduced to 20-35% of normal in ALD fibroblasts. It was completely normalized by gene transfer.\nConsequently, VLCFA content returned to normal in the patients' fibroblast cell lines in which they had previously accumulated. These results indicate that the recombinant\nALD localized in the peroxisomal membrane was functional and allowed a complete restoration of the VLCFA-CoA synthetase activity, deficient in ALD.\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7878038","rdfs:label":"Rescue in patient cells","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/75d0cc18-aacf-4f73-a748-a694061d01e6","type":"EvidenceLine","dc:description":"Rescue evidence in humans is awarded default points.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d5f6ad56-f70c-4d49-9aac-c5c1bbcffffb","type":"Finding","dc:description":"Cerebral adrenoleukodystrophy–specific neurologic function scale was used to evaluate the severity of gross neurologic dysfunction through an assessment for 15 disabilities across multiple domains. The 6 most severe disabilities, loss of communication, cortical blindness, tube feeding, total incontinence, wheelchair dependence, and complete loss of voluntary movement, were classified as major functional disability.\n\nAt the time of interim analysis, 15 of 17 patients were alive and free of major functional disabilities, maintaining a score on the neurological function scale of 0 to 1. Gadolinium enhancement was present at baseline in all patients, but had resolved by month 6 in 16 patients. Diffuse gadolinium enhancement reemerged in a few patients at several timepoints later; however the enhancement was less extensive than that seen at baseline.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28976817","rdfs:label":"Eichler_17 cerebral ALD patients_Rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e2de7dd8-aff7-452d-b4a0-7abc86126ad3","type":"EvidenceLine","dc:description":"Similar evidence has already been scored in PMID: 9256488, and therefore not scored again in this instance.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb5e8536-0756-4227-baf5-8bbcd548a445","type":"Finding","dc:description":"\"By gas chromatography, the CNS of hemizygous mutant mice displayed clearly elevated levels of saturated and monounsaturated C25, C26, and C28 fatty acids when compared with wild-type controls of the same age and sex, whereas in heterozygous females, intermediate levels were found (Fig. 3; Table I). The largest increase was observed for C26:0, which is also the case in human patients with ALD, suggesting that the underlying biochemical defects have been adequately modeled in the mouse.\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9418970","rdfs:label":"Forss-Petter KO Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/509ba7f2-f93d-47eb-b023-ca43e6aa5e1d","type":"EvidenceLine","dc:description":"The mouse model evidence recapitulates to a good degree the adult-onset phenotype of AMN and warrants a default score.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ecb695f-e546-4c12-b148-2a9a70c1a88a","type":"Finding","dc:description":"ABCD1-/- mice do not recapitulate choldhood-ALD, except for the elevated VLCFAs. In this study, authors evaluated older mice (15- and 20-month-old mice). Compared to 6mo and 15mo mice,, 20mo mice showed severe impairment in performance, falling off the rotarod in <20s on average. Motor activity of ABCD1-/- mice were examined in the open field mobility paradigm, which showed that 20mo mice displayed a significant reduction of exploratory activities or hypoactivity during all the testing period, compared to 15mo mice. Rearing behavior was significantly lesser in KO mice compared to WT at 15m and 20m of age. Sciatic nerves showed myelin and axon abnormalities: acute demyelination was absent, but axons with abnormally thick and disorganized myelin sheaths were encountered at 16m indicating focal hypermyelination. Quantitation of the proportion of total number of myelinated fibers versus fibers with myelin sheaths of irregular thickness, lacking axons revealed a significant effect due to the ALD gene inactivation, at 16m of age.\n\nNote, PMID: 15489218 describes a more severe phenotype of ABCD1 and ABCD2 double KO mice and the mitigation of VLCFA accumulation and neurodegenerative symptoms due to modulation of ABCD2 expression, suggesting redundancy among the two ABC transporters.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11875044","rdfs:label":"Pujol_AMN Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/198af236-de95-4b6a-8c37-0b6badf3bbe7","type":"EvidenceLine","dc:description":"Reduced points are awarded as the phenotype is not recapitulated, except for elevated VLCFAs","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4cfed85-1131-4f8a-a24b-6b768c270aa0","type":"Finding","dc:description":"\"In humans, the diagnosis of X-ALD is usually made by measuring VLCFA levels\nin plasma (51). In X-ALD mice, surprisingly, there is no detectable elevation of C24:0 or C26:0 (saturated fatty acids with indicated carbon chain length) in plasma (see Table 1). Based on the ratio of C26:0yC22:0, the index commonly used for X-ALD diagnosis (4, 5), there is virtually no difference between normal and X-ALD mice.Because VLCFAs accumulate in tissues of X-ALD patients, we measured total VLCFAs in various tissues from X-ALD mice, including brain, adrenal gland, heart, liver, and kidney. As shown in Table 2, the levels of saturated VLCFAs are elevated in all tissues measured in X-ALD mice but the extent of accumulation is variable from tissue to tissue...All these observations support the conclusion that X-ALD mice have biochemical defects that resemble to those found in hunam X-ALD but to a milder degree.\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9256488","rdfs:label":"X-ALD mouse created by targeted KO","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":4269,"specifiedBy":"GeneValidityCriteria7","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/g6v116HNRwk","type":"GeneValidityProposition","disease":"obo:MONDO_0018544","gene":"hgnc:61","modeOfInheritance":"obo:HP_0001417"},"version":"1.6","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_815e0f84-b530-4fd2-81a9-02e02bf352ee-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}